Warning letter

Natren Inc.: warning letter of Nov 21, 2006

FDA warning letter UCM076177 · Los Angeles District Office

Key facts

Reference number UCM076177
Company Natren Inc.
Subject Labeling/Promotional Claims False & Misleading/Misbranded/Adulterated
Issue date Nov 21, 2006
Posted date Nov 21, 2006
Issuing office Los Angeles District Office
Product type Unknown
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters